Welcome message from EASL Secretary General and Vice-Secretary
Welcome to Amsterdam to the International Liver Congress™ 2017 (ILC 2017), the 52nd annual meeting of the European Association for the Study of the Liver (EASL), the Home of Hepatology!
We are delighted to invite you to join the international liver community at the RAI Congress Centre, Amsterdam, The Netherlands from 19 to 23 April 2017.
In the digital communication era, ILC 2017 still provides a unique opportunity for clinicians and scientists from all over the world to meet not only to discuss clinical innovation and research challenges but also to interact socially, network and develop future collaborations. Although EASL is a professional medical organisation based in Europe, ILC has attracted over the past years, an increasing number of participants from 120 countries thanks to an exciting programme mixing state-of the art education and cutting edge science,
The 2017 ILC highlights comprise:
- Post graduate course entitled ‘A multidisciplinary approach to patients with liver disease’
- State of the art lectures on liver transplantation for HCC and cell growth control in cancer therapy
- Basic science seminar on hepatic regenerative medicine
- Late breaker session
- Clinical Grand Rounds and symposia
- EASL Clinical Practice Guidelines sessions
- Fusion session
- Young Investigators Forum and symposium
Selected sessions and posters will be webcasted and made available on the LiverTree™ for EASL members to view. Don’t forget to renew your EASL membership before 31st December 2016 to benefit from all educational platforms and services on offer.
Whether you are a young investigator, clinician, basic scientist, nurse, or a researcher, you will get the latest data in your specialty, and can broaden your horizons in Hepatology at ILC 2017. Take part in an exciting week of liver discoveries and exchange!
If you wish to share your data at ILC 2017, submit your research now.
Looking forward to seeing you in Amsterdam
EASL Secretary General
Tom Hemming Karlsen
Welcome message from the ILC 2017 Honorary President
Welcome to the 52nd annual EASL meeting. The International Liver Congress™.
Amsterdam has a fine history of academic pursuit and clinical service in hepatology and is an excellent venue for our 2017 meeting. Based on a unique canal system it is also an attractive city for accompanying partners.
It was in 1973 that I attended my first EASL meeting in Vittel, Eastern France. This 13th meeting turned out to be very lucky for me: having just finished my PhD on the immunological role of the liver with Roddy McSween in Glasgow, I was introduced to Sheila Sherlock who offered me a lectureship at the Royal Free. This began my career in hepatology and since then, I attended the EASL annual meeting every year for the following 40 years.
Over this period much of liver disease has become treatable if not curable. The first advances were in liver physiology but in many ways the most important have been in the viral liver diseases – beauty is in the eye of the beholder- but now we are seeing therapeutic advances in the fields of alcohol and obesity related disease and liver cancer and gene and stem cell therapy, established at the ‘proof of principle’ level, which will hopefully be major areas for clinical development in the next decade. The International Liver Congress™ aims to provide the current ‘state of the art’ for the practising clinician and also a projection into the future. I look forward to hearing about these advances at this coming meeting.
Almost as important as the content of the meeting and prospects for career networking, is the opportunity to meet past friends and make future acquaintances from across Europe and increasingly from the four corners of the globe. At a time when Britain has decided to leave the European Union, it is even more important to maintain clinical and scientific collaboration and friendships, and to recognise that the vast majority of NHS and university research staff in Britain voted to stay in the European Union!
I hope you enjoy and benefit from this year’s meeting both at a social and academic level and that this year even more than 10,000 people, our current record, attend.
Honorary President of The International Liver Congress™ 2017 and Emeritus Professor, Imperial College London.